EA201692563A1 - Способ увеличения количества жизнеспособных молочно-кислых бактерий и их полезные композиции - Google Patents

Способ увеличения количества жизнеспособных молочно-кислых бактерий и их полезные композиции

Info

Publication number
EA201692563A1
EA201692563A1 EA201692563A EA201692563A EA201692563A1 EA 201692563 A1 EA201692563 A1 EA 201692563A1 EA 201692563 A EA201692563 A EA 201692563A EA 201692563 A EA201692563 A EA 201692563A EA 201692563 A1 EA201692563 A1 EA 201692563A1
Authority
EA
Eurasian Patent Office
Prior art keywords
increasing
amount
acid bacteria
useful compositions
natural plant
Prior art date
Application number
EA201692563A
Other languages
English (en)
Other versions
EA034017B1 (ru
Inventor
Мухаммед Маджид
Сивакумар Арумугам
Фуркан Али
Original Assignee
Мухаммед Маджид
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мухаммед Маджид filed Critical Мухаммед Маджид
Publication of EA201692563A1 publication Critical patent/EA201692563A1/ru
Publication of EA034017B1 publication Critical patent/EA034017B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Настоящее изобретение раскрывает (i) стимулирующую рост активность природных растительных волокон в отношении Bacillus coagulans MTCC 5856; (ii) комбинацию природных растительных волокон и Bacillus coagulans MTCC 5856 для ингибирования грамотрицательных патогенных бактерий и (iii) образование короткоцепочечных жирных кислот (SCFA) при помощи Bacillus coagulans MTCC 5856 с использованием природных растительных волокон.
EA201692563A 2014-08-29 2015-08-29 Способы, основанные на культивировании bacillus coagulans mtcc 5856 в присутствии природных растительных волокон EA034017B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462043599P 2014-08-29 2014-08-29
US201462063453P 2014-10-14 2014-10-14
PCT/US2015/047608 WO2016033572A1 (en) 2014-08-29 2015-08-29 Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

Publications (2)

Publication Number Publication Date
EA201692563A1 true EA201692563A1 (ru) 2017-07-31
EA034017B1 EA034017B1 (ru) 2019-12-19

Family

ID=55400730

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692563A EA034017B1 (ru) 2014-08-29 2015-08-29 Способы, основанные на культивировании bacillus coagulans mtcc 5856 в присутствии природных растительных волокон

Country Status (14)

Country Link
US (2) US9717766B2 (ru)
EP (1) EP3185877B1 (ru)
JP (1) JP6630723B2 (ru)
KR (1) KR102089566B1 (ru)
CN (1) CN106573021B (ru)
AU (1) AU2015308650B2 (ru)
CA (1) CA2955111A1 (ru)
EA (1) EA034017B1 (ru)
MX (1) MX2017002452A (ru)
MY (1) MY174855A (ru)
PH (1) PH12017500059A1 (ru)
PL (1) PL3185877T3 (ru)
SG (1) SG11201700006UA (ru)
WO (1) WO2016033572A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018217228A1 (en) 2017-05-26 2018-11-29 Muhammed Majeed Beverage compositions containing bacillus coagulans mtcc 5856
EP3781279A2 (en) 2018-04-17 2021-02-24 Bien-Etre Labs, LLC Date palm medium compositions and methods
CN110537573A (zh) * 2018-05-28 2019-12-06 可口可乐公司 一种含孢子型凝结芽孢杆菌的常温酸性饮品的生产方法
CA3140038A1 (en) * 2019-05-13 2020-11-19 Sami-Sabinsa Group Limited Fructophilic lactic acid producing bacteria
CN110268847A (zh) * 2019-06-05 2019-09-24 云南大学 一种免腐熟生饼粕肥直接施用方法
CN110800438A (zh) * 2019-11-25 2020-02-18 广东海纳肥业有限公司 一种油柑的施肥方法
US20240141284A1 (en) * 2021-03-03 2024-05-02 Bien-Etre Labs, LLC Compositions and methods for cultivating environmental microorganisms and compositions derived therefrom

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4678896B2 (ja) * 1997-04-18 2011-04-27 ガネデン バイオテック，インコーポレイテッド 微生物感染を予防または制御するための共生Ｂａｃｉｌｌｕｓ芽胞の局所的使用
ES2258841T3 (es) * 1998-04-01 2006-09-01 Ganeden Biotech, Inc. Procedimientos para reducir el colesterol con esporas de bacillus coagulans, sistemas y composiciones asociados.
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
ATE293895T1 (de) * 1999-10-29 2005-05-15 Hunza Di Pistolesi Elvira E C Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
US20030004211A1 (en) * 2001-05-25 2003-01-02 Frank Corsini Carbohydrate modifying agent and drinks containing the modifying agent
US9101148B2 (en) * 2001-05-25 2015-08-11 Sbs Food Group Llc Carbohydrate modifying agent and drinks containing the modifying agent
US20040197277A1 (en) * 2001-08-24 2004-10-07 The Procter & Gamble Company Chewable compositions with probiotic agents
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
JP2007518394A (ja) * 2003-08-14 2007-07-12 ザ バイオ バランス コーポレイション 細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
JP5081242B2 (ja) * 2006-08-04 2012-11-28 バイオニア コーポレイション 人間母乳から分離したプロバイオティック活性、及び体重増加抑制活性を有する乳酸菌
KR101003654B1 (ko) * 2008-08-27 2010-12-23 삼성전기주식회사 반도체 패키지용 트랜스포머
WO2010122106A1 (en) * 2009-04-23 2010-10-28 Bacterfield International S.A. Extruded food products comprising probiotic micro-organisms
CN101792727B (zh) * 2010-04-02 2012-05-30 上海交通大学 一株凝结芽孢杆菌及其在l-乳酸钠制备中的应用
CN102690764B (zh) * 2010-05-20 2013-07-10 上海交通大学 用于制备l-乳酸的凝结芽孢杆菌及其应用方法
WO2012135499A1 (en) * 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
DK2773744T3 (en) * 2011-11-02 2019-04-08 Univ Texas Tech System Media compositions to promote bacterial and fungal growth
EP2922926A4 (en) * 2012-11-26 2016-07-20 Progel Pty Ltd COATING COMPOSITION
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US9596861B2 (en) * 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof

Also Published As

Publication number Publication date
AU2015308650A1 (en) 2017-02-16
JP2017532017A (ja) 2017-11-02
KR20170020913A (ko) 2017-02-24
KR102089566B1 (ko) 2020-03-16
WO2016033572A8 (en) 2017-02-02
AU2015308650B2 (en) 2018-04-05
CA2955111A1 (en) 2016-03-03
US9717766B2 (en) 2017-08-01
JP6630723B2 (ja) 2020-01-15
WO2016033572A1 (en) 2016-03-03
US10293008B2 (en) 2019-05-21
EP3185877A4 (en) 2018-04-25
AU2015308650A8 (en) 2017-02-23
PH12017500059B1 (en) 2017-05-15
SG11201700006UA (en) 2017-01-27
CN106573021B (zh) 2020-09-11
EP3185877B1 (en) 2020-04-01
PH12017500059A1 (en) 2017-05-15
US20170274023A1 (en) 2017-09-28
US20160058805A1 (en) 2016-03-03
MX2017002452A (es) 2017-10-23
PL3185877T3 (pl) 2020-11-02
EP3185877A1 (en) 2017-07-05
MY174855A (en) 2020-05-19
EA034017B1 (ru) 2019-12-19
CN106573021A (zh) 2017-04-19

Similar Documents

Publication Publication Date Title
EA201692563A1 (ru) Способ увеличения количества жизнеспособных молочно-кислых бактерий и их полезные композиции
CL2018003631A1 (es) Línea ns-b50027-4 de canola innata transgénica y semillas de la misma.
MX2015010306A (es) Composicion que comprende una gougerotina aislada y un fungicida.
UY33917A (es) ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?.
MX2016017365A (es) Composicion que contiene minoxidil para el crecimiento del pelo.
UY34293A (es) Composición acuosa para acelerar la secreción de alfa-amilasa en la germinación de las semillas de las plantas
MY195933A (en) Method for Purification of Animal or Vegetable Fats
EA201692076A1 (ru) Новые ингибиторы нитрификации
MX2015010310A (es) Composiciones que comprenden una gougerotina y un insecticida.
EA201691363A1 (ru) Стабилизированные силикатные композиции и их применение в качестве антиперспирантных композиций
BR112016016539A2 (pt) micro-organismos recombinantes enriquecidos com carboidratos
MX2017000374A (es) Metodos y composiciones que regulan el crecimiento del pelo.
UY34169A (es) ?compuestos heterociclicos microbiocidas,composiciones que los contienen, y métodos para controlar o prevenir la infestación de plantas
ECSP17040052A (es) Consorcios bacterianos sinergísticos para movilizar fósforo del suelo
EA201990128A1 (ru) Культуры клеточных линий из растений, принадлежащих к роду harpagophytum
MX2016008221A (es) Composiciones prebioticas para el cuidado oral que contienen un alquilglucosido.
ZA202100594B (en) Solid cleansing compositions and methods for the same
WO2016060935A3 (en) Compositions and methods of improving the digestibility of animal feed
UA117372C2 (uk) Композиція та спосіб поліпшення продуктивності рослин
EA201600097A1 (ru) Применение выбранных пиридон карбоксамидов или их солей в качестве активных веществ против абиотического стресса растений
MX2016012758A (es) Composicion hiperosmolar de acido hialuronico.
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.
MX2016011413A (es) Formulaciones que comprenden xiloglucano polimérico como portador para agentes agronómicamente beneficiosos.
MX2020008793A (es) Mezclas de forclorfenuron y usos de estas.
EA201590481A1 (ru) Применение замещенных 2,3-дигидро-1-бензофуран-4-карбоновых кислот или их солей в качестве биологически активных веществ против абиотического стресса растений